In ₹ Crore except Per Share Latest Annual	SUKHJITS FY26	SARVESHWAR FY26	NATHBIOGEN FY26	REGAAL FY26	Peer Average
Valuation — at last close
P/E	25.20×	12.24×	◆ 6.31×	15.26×	11.27× +124%
P/B	0.78×	0.92×	◆ 0.37×	1.88×	1.05× -26%
EV/EBITDA	8.29×	10.34×	◆ 5.99×	11.54×	9.29× -11%
Market Cap	₹445 Cr	₹437 Cr	₹252 Cr	₹918 Cr	₹536 Cr -17%
Growth
Revenue CAGR 3Y	-0.33%	◆ 24.98%	13.88%	—	19.43% -102%
Net Income CAGR 3Y	-24.72%	◆ 59.78%	5.93%	—	32.86% -175%
Revenue YoY (latest Q)	◆ 29.71%	18.81%	15.76%	-18.02%	5.52% +439%
Net Income YoY (latest Q)	◆ 255.12%	17.04%	-13.46%	46.99%	16.86% +1413%
Profitability
EBITDA Margin	5.77%	4.91%	◆ 11.78%	11.16%	9.28% -38%
Net Income Margin	1.89%	2.36%	◆ 9.35%	4.90%	5.54% -66%
Return on Common Equity	4.87%	8.13%	6.28%	◆ 11.35%	8.59% -43%
Return on Capital Employed	6.48%	◆ 16.11%	7.11%	12.07%	11.76% -45%
Return on Assets	2.55%	3.19%	3.92%	◆ 4.16%	3.76% -32%
Credit & Quality
Total Debt/Equity	0.58×	0.52×	◆ 0.20×	1.25×	0.66× -12%
Interest Coverage	1.54×	2.44×	3.03×	◆ 3.58×	3.02× -49%
Scale — latest FY
Revenue / Total Income	₹1,432 Cr	₹1,346 Cr	₹445 Cr	₹1,134 Cr	₹975 Cr +47%
Net Income	₹27 Cr	₹31.8 Cr	₹41.6 Cr	₹55.6 Cr	₹43 Cr -37%
Total Assets	₹1,089 Cr	₹1,089 Cr	₹1,097 Cr	₹1,337 Cr	₹1,174 Cr -7%
EPS	₹5.65	₹0.29	₹20.98	₹5.86	₹9.04 -38%
Book Value per Share	₹181.61	₹3.87	₹358.06	₹47.65	₹136.53 +33%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.